Skip to main content
PMC home page
BMC Infectious Diseases logoLink to BMC Infectious Diseases
. 2020 Feb 11;20:122. doi: 10.1186/s12879-020-4848-8

Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events

Ralph Rogers 1, Kapil Saharia 2, Aditya Chandorkar 2, Zoe F Weiss 1,3, Kendra Vieira 1, Sophia Koo 3, Dimitrios Farmakiotis 1,✉
PMCID: PMC7011558  PMID: 32046661

Correction to: BMC Infectious Diseases (2020) 20:58.

https://doi.org/10.1186/s12879-020-4787-4

After publication of the original article [1], we were notified that an author’s family name has been erroneously spelled. Aditya Chandrokar should be replaced with Aditya Chandorkar.

The original article has been corrected as well.

Reference

  • 1.Rogers et al. Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events. BMC Infectious Diseases (2020) 20:58, doi: 10.1186/s12879-020-4787-4 [DOI] [PMC free article] [PubMed]

Articles from BMC Infectious Diseases are provided here courtesy of BMC

RESOURCES